A nationwide wastewater-based assessment of metformin consumption across Australia

A nationwide wastewater-based assessment of metformin consumption across Australia

Metformin is the most widely used drug to treat type 2 diabetes. Monitoring spatial patterns of metformin use could provide new insights into treatment of type 2 diabetes and the distribution among populations. This study applied a wastewater-based epidemiological (WBE) approach to estimate metformi...

Full description

Bibliographic Details
Main Authors:	Dan Yang, Qiuda Zheng, Phong K. Thai, Fahad Ahmed, Jake W. O'Brien, Jochen F. Mueller, Kevin V. Thomas, Ben Tscharke
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Environment International
Subjects:	Wastewater Metformin Type 2 diabetes Socio-economic factors Spatial pattern
Online Access:	http://www.sciencedirect.com/science/article/pii/S0160412022002094

Similar Items

National wastewater reconnaissance of artificial sweetener consumption and emission in Australia
by: Dandan Li, et al.
Published: (2020-10-01)

Socioeconomic status and public health in Australia: A wastewater-based study
by: Nikolaos I. Rousis, et al.
Published: (2022-09-01)

Metformin reduces energy consumption and increases satiety in obese children
by: Teona Albertovna Shvangiradze
Published: (2015-11-01)

Wastewater bacteria remediating the pharmaceutical metformin: Genomes, plasmids and products
by: Betsy M. Martinez-Vaz, et al.
Published: (2022-12-01)

Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study
by: Eunki Chung, et al.
Published: (2024-03-01)

Pleiotropic Effects of Metformin in Osteoarthritis
by: Sevdalina Nikolova Lambova
Published: (2023-02-01)

Metformin and Glaucoma—Review of Anti-Fibrotic Processes and Bioenergetics
by: Daire J. Hurley, et al.
Published: (2021-08-01)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)

A revised excretion factor for estimating ketamine consumption by wastewater-based epidemiology – Utilising wastewater and seizure data
by: Peng Du, et al.
Published: (2020-05-01)

Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)

Role of metformin in radiotherapy and chemotherapy
by: Yasemin Benderli Cihan
Published: (2019-03-01)

Metformin: When Should We Fear Lactic Acidosis?
by: Stefania Di Mauro, et al.
Published: (2022-07-01)

Metformin in skin diseases
by: Damian Kadylak, et al.
Published: (2021-05-01)

Effect of metformin on semen quality
by: Saleem Ali Banihani

Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
by: Min-Ho Kim, et al.
Published: (2021-12-01)

Metformin use and severe dengue in diabetic adults
by: Lye, David Chien, et al.
Published: (2018)

Metformin-associated lactic acidosis: it really happens!
by: Faisal Hasan, et al.
Published: (2017-01-01)

Anti-aging properties of metformin
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2021-09-01)

Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)

Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19
by: Elnaz Shaseb, et al.
Published: (2023-07-01)

Does metformin play a role in the treatment of acne?
by: Ana Maria A. STANESCU, et al.
Published: (2019-12-01)

COMPARISON OF BLADDER CANCER CELLS APOPTOSIS INDUCED BY METFORMIN, CISPLATIN, AND COMBINATION OF METFORMIN-CISPLATIN: IN VITRO STUDY
by: Arifai Lumbangaol, et al.
Published: (2020-01-01)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

Metformin and sleep disorders
by: Somsri Wiwanitkit, et al.
Published: (2012-01-01)

Metformin in Reproductive Biology
by: Melanie Faure, et al.
Published: (2018-11-01)

The Role and Mechanism of Metformin in Inflammatory Diseases
by: Lin H, et al.
Published: (2023-11-01)

Erythroderma and Chronic Lichenification Due to Metformin
by: Javier Moreno Díaz, et al.
Published: (2019-05-01)

Metformin improves diabetic kidney disease
by: Beladi Mousavi Seyed Seifollah, et al.
Published: (2012-01-01)

Novel Metformin Indications and Skin Disorders
by: Ramadan S. Hussein, et al.
Published: (2022-12-01)

Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)

Metformin protects hepatocytes against oxidative stress-induced apoptosis
by: Svetlana Yur'evna Vorotnikova
Published: (2015-12-01)

Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer
by: Domenico Conza, et al.
Published: (2023-08-01)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
by: Pratap Kumar, et al.
Published: (2012-01-01)

Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients
by: Mahmud Shaker, et al.
Published: (2010-10-01)

New Metformin–Citric Acid Pharmaceutical Molecular Salt: Improving Metformin Physicochemical Properties
by: Cristóbal Verdugo-Escamilla, et al.
Published: (2022-12-01)

Physicochemical stability of three generic brands of metformin in solution
by: Radamés Alemón-Medina, et al.
Published: (2014-07-01)

Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
by: Seung In Seo, et al.
Published: (2022-02-01)

The effect of metformin on senescence of T lymphocytes
by: Jia Yang, et al.
Published: (2023-12-01)

Effects of metformin on oral lesions
by: Kata Sára Somogyi, et al.
Published: (2022-06-01)